4 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Addictions and Lifestyles In Contemporary Europe – Reframing Addictions Project (ALICE RAP)
Date du début: 1 avr. 2011, Date de fin: 31 mars 2016,
ALICE RAP is a Europe wide project of 43 partner research institutions involving 107 researchers from 25 European countries providing 1000 months of a plurality of scientific endeavour to analyse the place and challenges of addictions and lifestyles to the cohesion, organization and functioning of contemporary European society. Through integrated multidisciplinary research, a wide range of factors ...
Voir le projet
46
Participants partenaires
TERMINÉ
Structural Transformation to Achieve Gender Equality in Science (STAGES)
Date du début: 1 janv. 2012, Date de fin: 31 déc. 2015,
STAGES has the general aim of making the most of the unprecedented opportunity, provided for by the EC, to leave the logic of pilot projects behind and launch structural change strategies addressing the many and interconnected layers of the problem of gender inequality in science from an integrated perspective, deeply involving human resources management in research institutions, modifying and gen ...
Voir le projet
7
Participants partenaires
TERMINÉ
Pharmacogenomic biomarkers as clinical decision making tools for clozapine treatment of schizophrenia (CRESTAR)
Date du début: 1 nov. 2011, Date de fin: 31 oct. 2015,
Treatment resistant schizophrenia (TRS) is the most disabling of all psychiatric illnesses, affecting about 1/3 of patients (~1 million Europeans), a considerable economic and social burden. First-line treatments include atypical (e.g. olanzapine) and typical (e.g. haloperidol) antipsychotics. The original atypical, clozapine, is a final option, and although it is the only antipsychotic shown to b ...
Voir le projet
11
Participants partenaires
TERMINÉ
Pharmacoepidemiolocal Research on Outcomes of Therapeutics by a European ConsorTium (PROTECT)
Date du début: 1 sept. 2009, Date de fin: 30 avr. 2015,
Recent pharmacovigilance (PV) issues have led to questions regarding the ability of the current PV system to meet the global needs. Controversies around the assessment of spontaneous reports and conflicting results from pharmacoepidemiology studies may lead to delay in, or inappropriate, regulatory decisions. The PROTECT consortium, consisting of 20 core partners lead by the European Medicines Age ...
Voir le projet